GlassScriptPhysician profile
Ehtesham Mustafa
NPI 1104484609
$2,299.44
in general payments reported to CMS, 2019-2025
33 companies · $1,000 in 2025
The $1,000 reported for 2025 was more than what 83% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $14.59 · 2022: $192 · 2023: $89.39 · 2024: $1,004 · 2025: $1,000.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,058 · Education: $18.85 · Entertainment: $16.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,057.60 |
| Education | $18.85 |
| Entertainment | $16.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $447.21 | 2022-2025 | |
| Abbvie INC. | $408.25 | 2024-2025 | |
| Novo Nordisk INC | $259.79 | 2023-2025 | Wegovy, Ozempic, Rybelsus |
| Amgen INC. | $141.01 | 2021-2025 | Repatha, Evenity, Otezla |
| Lilly USA, LLC | $114.57 | 2024-2025 | Zepbound, Mounjaro |
| Boehringer Ingelheim Pharmaceuticals, INC. | $112.10 | 2022-2025 | Jardiance, Tradjenta |
| Dexcom, INC. | $72.52 | 2024-2025 | Dexcom G6 Transmitter |
| Exact Sciences Corporation | $51.74 | 2025 | Cologuard Collection Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $49.67 | 2024-2025 | Xifaxan |
| Inspire Medical Systems, INC. | $45.68 | 2024-2025 | Inspire |
| Lundbeck LLC | $45.59 | 2024-2025 | Vyepti |
| Astrazeneca Pharmaceuticals LP | $44.18 | 2024-2025 | Airsupra, Breztri |
| Sumitomo Pharma America, INC. | $41.57 | 2025 | Gemtesa |
| Phathom Pharmaceuticals, INC. | $39.25 | 2024-2025 | Voquezna |
| Axsome Therapeutics, INC. | $37.37 | 2025 | Symbravo |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $36.46 | 2024 | (Ck6) Holter |
| Novartis Pharmaceuticals Corporation | $32.83 | 2024 | |
| Astellas Pharma US INC | $31.48 | 2024-2025 | Veozah |
| Takeda Pharmaceuticals U.S.A., INC. | $30.43 | 2024 | Trintellix |
| Glaxosmithkline, LLC. | $28.98 | 2023-2024 | Shingrix, Arexvy, Bexsero |
| Esperion Therapeutics, INC. | $26.79 | 2022-2024 | Nexletol |
| Otsuka America Pharmaceutical, INC. | $21.54 | 2024 | Rexulti |
| Daiichi Sankyo INC. | $19.62 | 2024 | Injectafer |
| Biohaven Pharmaceutical Holding Company LTD. | $18.56 | 2022 | |
| Edwards Lifesciences Corporation | $18.51 | 2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Merck Sharp & Dohme LLC | $18.48 | 2024 | Gardasil 9, Gardasil, Capvaxive |
| Optos, INC. | $16.74 | 2023 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Teva Pharmaceuticals USA, INC. | $15.69 | 2025 | Ajovy |
| Abbott Laboratories | $15.65 | 2025 | Freestyle Libre 3 |
| Sanofi Pasteur INC. | $14.92 | 2022 | |
| Medtronic, INC. | $14.64 | 2025 | Inceptiv |
| Amneal Pharmaceuticals LLC | $13.93 | 2025 | Unithroid |
| Insightec,INC | $13.69 | 2023 | Exablate |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ehtesham Mustafa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.